Skip to content

A cluster randomized controlled trial to evaluate a disease and care-management intervention for cardiovascular prevention in primary care: The Raffaello Project.

Effectiveness of a disease and care-management intervention in primary care versus usual care in controlling cardiovascular risk factors in subjects at increased cardiovascular risk

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000813987
Acronym
Raffaello project
Enrollment
900
Registered
2011-08-03
Start date
2008-03-25
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

“Project Raffaello” is a Research Project to evaluate the efficacy of an innovative model of healthcare management in prevention of cardiovascular diseases. The intervention evaluated is the “Care Management Team” (General Practitioner, Nurse as Care Manager, Patient and any Specialist needed) with the mission to define and apply patient personalized health plan based on international guidelines on CVD prevention. Patients participating in the program received (a) on-going, one-on-one health and motivational coaching sessions; (b) customized, personalized, patient focused care plans; (c) education materials, and (d) service coordination between providers.

Interventions

The overall duration of interventions is 12 months. In Arm 1: The disease and care-management intervention evaluated is the “Care Management Team” (General Practitioner, Nurse as Care Manager, Patient and any Specialist needed) with the mission to define and apply tailored care plans for patients based on international guidelines on cardiovascular disease prevention. The intervention develops in 6 main steps: 1. Patient assessment. The GP assess patient health status and his/her cardiovascular

The overall duration of interventions is 12 months. In Arm 1: The disease and care-management intervention evaluated is the “Care Management Team” (General Practitioner, Nurse as Care Manager, Patient and any Specialist needed) with the mission to define and apply tailored care plans for patients based on international guidelines on cardiovascular disease prevention. The intervention develops in 6 main steps: 1. Patient assessment. The GP assess patient health status and his/her cardiovascular risk. 2. Health goals definition. The GP sets health goals on the basis of evidence-based clinical recommendations. 3. Tailored health plan development. The GP and the CM elaborate a patient tailored health plan integrating clinical and care treatment goals, patient preferences and priorities and implementation strategies. 4. Patient education and support. The Care Manager deliver ongoing patient coaching, providing patients with information, motivation and support. Counselling occurs through recurrent telephone contacts and face-to-face meetings at the GP group practices. 5. Health plan implementation and results monitoring. The Care Manager manages counselling sessions, follow up visits, laboratory examinations, at frequency of patient recall established by health plan. 6. Periodic revision of healthcare plan. The Care Manager, in the light of the monitoring results, could adjust strategies and goals in agreement with the GP and the patient if necessary. Clinical decisional algorithms, based on international guidelines of cardiovascular disease prevention were used to guide Care Manager practice: the frequency of follow-up and laboratory examinations, when to refer to GP for drugs dosage adjustment/change or when to refer to specialists. In Arm 2: Control practices provided usual care.

Sponsors

Marche Regional Healthcare Agency
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients with at least one of the following cardiovascular risk factors were considered eligible for the project: Arterial blood pressure: >=140/90 mmHg Dyslipidemia: LDL >=160 mg/dL for primary prevention and LDL >=100 mg/dL for secondary prevention Diabetes mellitus: Hb1AC >=7% Obesity: BMI >=30 Smoking status (at least one cigarette/day)

Exclusion criteria

Patients did not provide informed consent or presented with one of the following condition were excluded from the trial: Mental illness Institutionalization in a nursing home Pregnant status

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 21, 2026